13F Data
13F filer · CIK 2103725

AIHC Capital Management Ltd

CENTRAL, K3 · filing since Q4 2025 · last filing Aug 13, 2026
Reported value
$104.2M
$-15.4M vs prior
Positions
4
New / sold out
0 / 1
Added / reduced
2 / 1
Turnover
14.3%
buys $16.0M · sells $100.5M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedORIC PHARMACEUTICALS INC+1,368,909+55.7%+$14.8M
AddedNOVABRIDGE BIOSCIENCES+615,100+27.2%+$1.2M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedREVOLUTION MEDICINES INC-525,841-63.4%$-98.5M
Sold outCOGENT BIOSCIENCES INC-51,402-100.0%$-2.0M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2025: $106.7MQ1 2026: $119.7MQ2 2026: $104.2M
Q4 2025Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1REVOLUTION MEDICINES INCCOM303,133$56.8M54.46%
2ORIC PHARMACEUTICALS INCCOM3,828,460$41.5M39.77%
3NOVABRIDGE BIOSCIENCESSPONSORED ADS2,878,033$5.6M5.38%
4KORRO BIO INCCOM30,265$398.9K0.38%